| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Nucleus | 19 | 2022 | 608 | 2.550 |
Why?
|
| DNA Helicases | 11 | 2017 | 187 | 1.840 |
Why?
|
| Chromatin | 10 | 2024 | 599 | 1.690 |
Why?
|
| Nuclear Proteins | 13 | 2017 | 750 | 1.690 |
Why?
|
| Transcription Factors | 18 | 2022 | 1471 | 1.590 |
Why?
|
| Nuclear Matrix | 8 | 2022 | 28 | 0.960 |
Why?
|
| Epigenesis, Genetic | 4 | 2024 | 357 | 0.940 |
Why?
|
| RNA Transport | 3 | 2015 | 29 | 0.830 |
Why?
|
| Breast Neoplasms | 8 | 2018 | 1118 | 0.800 |
Why?
|
| Mammary Glands, Human | 4 | 2015 | 53 | 0.790 |
Why?
|
| Ribonucleoproteins | 2 | 2022 | 112 | 0.780 |
Why?
|
| RNA, Long Noncoding | 1 | 2024 | 152 | 0.770 |
Why?
|
| RNA | 7 | 2022 | 401 | 0.730 |
Why?
|
| Chromatin Assembly and Disassembly | 8 | 2018 | 229 | 0.690 |
Why?
|
| Fluorescence Recovery After Photobleaching | 7 | 2013 | 23 | 0.680 |
Why?
|
| Antigens, Nuclear | 6 | 2022 | 19 | 0.660 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 5 | 2015 | 141 | 0.650 |
Why?
|
| Cytoskeleton | 5 | 2016 | 137 | 0.630 |
Why?
|
| Mitosis | 5 | 2018 | 208 | 0.620 |
Why?
|
| Nuclear Matrix-Associated Proteins | 5 | 2015 | 14 | 0.600 |
Why?
|
| RNA-Binding Proteins | 7 | 2015 | 386 | 0.600 |
Why?
|
| Microscopy, Fluorescence | 7 | 2016 | 392 | 0.560 |
Why?
|
| Adenosine Triphosphate | 5 | 2015 | 289 | 0.560 |
Why?
|
| Human Embryonic Stem Cells | 1 | 2016 | 35 | 0.530 |
Why?
|
| RNA, Messenger | 8 | 2016 | 1463 | 0.520 |
Why?
|
| Cell Proliferation | 8 | 2016 | 941 | 0.500 |
Why?
|
| Epithelial Cells | 5 | 2016 | 391 | 0.450 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 188 | 0.400 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 169 | 0.390 |
Why?
|
| Adenosine Triphosphatases | 4 | 2015 | 253 | 0.390 |
Why?
|
| RNA, Small Interfering | 5 | 2015 | 858 | 0.380 |
Why?
|
| DEAD-box RNA Helicases | 2 | 2013 | 79 | 0.380 |
Why?
|
| Protein Binding | 9 | 2013 | 1555 | 0.380 |
Why?
|
| Humans | 50 | 2024 | 59395 | 0.370 |
Why?
|
| HeLa Cells | 8 | 2015 | 526 | 0.370 |
Why?
|
| Cell Line, Tumor | 12 | 2016 | 1368 | 0.350 |
Why?
|
| Chromosomes, Human | 1 | 2011 | 53 | 0.350 |
Why?
|
| Amyotrophic Lateral Sclerosis | 4 | 2024 | 480 | 0.350 |
Why?
|
| Basement Membrane | 2 | 2010 | 25 | 0.350 |
Why?
|
| Active Transport, Cell Nucleus | 4 | 2021 | 108 | 0.350 |
Why?
|
| Cytoplasm | 5 | 2013 | 270 | 0.320 |
Why?
|
| Cell Line | 9 | 2017 | 1983 | 0.320 |
Why?
|
| Gene Expression Regulation | 7 | 2017 | 1551 | 0.320 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2009 | 75 | 0.300 |
Why?
|
| RNA Splicing | 5 | 2015 | 159 | 0.290 |
Why?
|
| Biochemistry | 1 | 2009 | 50 | 0.290 |
Why?
|
| RNA-Binding Protein FUS | 2 | 2021 | 53 | 0.280 |
Why?
|
| Animals | 25 | 2024 | 19642 | 0.280 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2018 | 474 | 0.270 |
Why?
|
| Desmosomes | 1 | 2006 | 7 | 0.270 |
Why?
|
| Hemidesmosomes | 1 | 2006 | 6 | 0.270 |
Why?
|
| Carcinogenesis | 2 | 2018 | 118 | 0.260 |
Why?
|
| Cell Nucleolus | 3 | 2016 | 68 | 0.240 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2013 | 193 | 0.230 |
Why?
|
| Gene Knockdown Techniques | 3 | 2016 | 194 | 0.230 |
Why?
|
| Recombinant Fusion Proteins | 6 | 2011 | 490 | 0.220 |
Why?
|
| Neoplasms | 4 | 2018 | 1231 | 0.220 |
Why?
|
| DNA Repair | 2 | 2016 | 242 | 0.210 |
Why?
|
| Microscopy | 3 | 2016 | 90 | 0.210 |
Why?
|
| Exons | 1 | 2004 | 191 | 0.210 |
Why?
|
| Transfection | 6 | 2015 | 675 | 0.200 |
Why?
|
| Adenosine Deaminase | 1 | 2002 | 17 | 0.200 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2024 | 139 | 0.200 |
Why?
|
| Stress, Physiological | 1 | 2024 | 185 | 0.200 |
Why?
|
| Green Fluorescent Proteins | 5 | 2015 | 354 | 0.200 |
Why?
|
| Neurodegenerative Diseases | 1 | 2024 | 134 | 0.190 |
Why?
|
| DNA | 2 | 2017 | 805 | 0.190 |
Why?
|
| Extracellular Matrix | 2 | 2016 | 132 | 0.190 |
Why?
|
| Fluorescent Antibody Technique | 4 | 2017 | 217 | 0.190 |
Why?
|
| Head and Neck Neoplasms | 1 | 2022 | 148 | 0.180 |
Why?
|
| Nuclear Pore Complex Proteins | 1 | 2021 | 26 | 0.180 |
Why?
|
| Kinetics | 4 | 2011 | 750 | 0.180 |
Why?
|
| Histones | 4 | 2017 | 456 | 0.180 |
Why?
|
| Microscopy, Electron | 2 | 2016 | 247 | 0.170 |
Why?
|
| Proteome | 2 | 2015 | 141 | 0.170 |
Why?
|
| Protein Biosynthesis | 1 | 2002 | 297 | 0.170 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2018 | 82 | 0.160 |
Why?
|
| Melanoma | 1 | 2022 | 318 | 0.160 |
Why?
|
| Mutation | 8 | 2024 | 2455 | 0.160 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2017 | 258 | 0.150 |
Why?
|
| Core Binding Factor alpha Subunits | 1 | 2018 | 20 | 0.150 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2016 | 59 | 0.150 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2018 | 62 | 0.150 |
Why?
|
| Macromolecular Substances | 3 | 2009 | 160 | 0.140 |
Why?
|
| Myoblasts, Skeletal | 1 | 2017 | 12 | 0.140 |
Why?
|
| Casein Kinase II | 1 | 2017 | 16 | 0.140 |
Why?
|
| Protein Subunits | 2 | 2010 | 165 | 0.140 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2017 | 168 | 0.140 |
Why?
|
| Transcription, Genetic | 3 | 2016 | 841 | 0.140 |
Why?
|
| Matrix Attachment Regions | 1 | 2017 | 4 | 0.140 |
Why?
|
| Cell Nucleus Structures | 1 | 2016 | 2 | 0.140 |
Why?
|
| Nuclear Pore | 1 | 2016 | 22 | 0.140 |
Why?
|
| Female | 11 | 2018 | 30736 | 0.140 |
Why?
|
| Blotting, Western | 3 | 2013 | 582 | 0.130 |
Why?
|
| Azabicyclo Compounds | 1 | 2016 | 5 | 0.130 |
Why?
|
| Binding Sites | 3 | 2011 | 881 | 0.130 |
Why?
|
| Integrin alpha5 | 2 | 2013 | 7 | 0.130 |
Why?
|
| DNA-Binding Proteins | 3 | 2016 | 1151 | 0.130 |
Why?
|
| Molecular Probes | 1 | 2016 | 29 | 0.130 |
Why?
|
| Signal Transduction | 5 | 2018 | 2899 | 0.130 |
Why?
|
| RNA, Nuclear | 1 | 2015 | 13 | 0.120 |
Why?
|
| Lipogenesis | 1 | 2016 | 65 | 0.120 |
Why?
|
| Neurons | 1 | 2021 | 862 | 0.120 |
Why?
|
| Pyridines | 1 | 2016 | 98 | 0.120 |
Why?
|
| Dipeptides | 1 | 2015 | 60 | 0.120 |
Why?
|
| RNA Polymerase II | 2 | 2015 | 72 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 1 | 2015 | 74 | 0.120 |
Why?
|
| Genome, Human | 1 | 2017 | 224 | 0.120 |
Why?
|
| Protein Transport | 6 | 2017 | 399 | 0.120 |
Why?
|
| Cells, Cultured | 3 | 2017 | 2092 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 4 | 2004 | 656 | 0.110 |
Why?
|
| Mice | 11 | 2016 | 10286 | 0.110 |
Why?
|
| RNA Polymerase I | 2 | 2011 | 9 | 0.110 |
Why?
|
| Lipids | 1 | 2016 | 301 | 0.110 |
Why?
|
| DNA Replication | 1 | 2016 | 228 | 0.110 |
Why?
|
| Doxycycline | 2 | 2011 | 42 | 0.110 |
Why?
|
| RNA Interference | 5 | 2016 | 590 | 0.110 |
Why?
|
| Frontotemporal Dementia | 1 | 2015 | 136 | 0.110 |
Why?
|
| Cytoplasmic Granules | 1 | 2013 | 51 | 0.110 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2013 | 21 | 0.110 |
Why?
|
| Genome | 1 | 2016 | 257 | 0.110 |
Why?
|
| Chromones | 1 | 2013 | 18 | 0.100 |
Why?
|
| Nucleocytoplasmic Transport Proteins | 1 | 2013 | 10 | 0.100 |
Why?
|
| Wnt3 Protein | 1 | 2012 | 3 | 0.100 |
Why?
|
| Cell Cycle | 2 | 2015 | 382 | 0.100 |
Why?
|
| Morpholines | 1 | 2013 | 86 | 0.100 |
Why?
|
| Sirolimus | 1 | 2013 | 88 | 0.100 |
Why?
|
| Homeostasis | 1 | 2015 | 346 | 0.100 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 117 | 0.100 |
Why?
|
| Methyltransferases | 1 | 2011 | 52 | 0.090 |
Why?
|
| Oxidative Stress | 1 | 2013 | 279 | 0.090 |
Why?
|
| RNA Precursors | 1 | 2011 | 74 | 0.090 |
Why?
|
| Breast | 1 | 2013 | 174 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 836 | 0.090 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2011 | 89 | 0.090 |
Why?
|
| Cell Adhesion | 4 | 2015 | 206 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 628 | 0.090 |
Why?
|
| Video Recording | 1 | 2011 | 126 | 0.090 |
Why?
|
| Models, Biological | 3 | 2015 | 1142 | 0.090 |
Why?
|
| RNA, Small Nucleolar | 1 | 2010 | 8 | 0.090 |
Why?
|
| Integrin beta1 | 1 | 2010 | 28 | 0.090 |
Why?
|
| Carrier Proteins | 1 | 2015 | 697 | 0.080 |
Why?
|
| Intranuclear Space | 1 | 2010 | 5 | 0.080 |
Why?
|
| Microtubules | 2 | 2015 | 211 | 0.080 |
Why?
|
| Intracellular Space | 1 | 2010 | 34 | 0.080 |
Why?
|
| Proteins | 1 | 2015 | 730 | 0.080 |
Why?
|
| Cell Survival | 3 | 2016 | 559 | 0.080 |
Why?
|
| Epigenomics | 1 | 2010 | 54 | 0.080 |
Why?
|
| NIH 3T3 Cells | 3 | 2016 | 95 | 0.080 |
Why?
|
| Up-Regulation | 1 | 2010 | 364 | 0.080 |
Why?
|
| Cell Differentiation | 3 | 2018 | 1302 | 0.080 |
Why?
|
| Phenotype | 2 | 2018 | 1137 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2012 | 619 | 0.080 |
Why?
|
| Cell Lineage | 2 | 2007 | 258 | 0.080 |
Why?
|
| Disease Models, Animal | 1 | 2015 | 2049 | 0.080 |
Why?
|
| Asparagine | 1 | 2008 | 24 | 0.070 |
Why?
|
| Molecular Biology | 1 | 2009 | 66 | 0.070 |
Why?
|
| Lysine | 1 | 2008 | 75 | 0.070 |
Why?
|
| Phosphorylation | 3 | 2017 | 883 | 0.070 |
Why?
|
| Animals, Genetically Modified | 2 | 2021 | 280 | 0.070 |
Why?
|
| Mutant Proteins | 1 | 2008 | 103 | 0.070 |
Why?
|
| Point Mutation | 1 | 2008 | 160 | 0.070 |
Why?
|
| Genes, rRNA | 1 | 2007 | 7 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2010 | 339 | 0.070 |
Why?
|
| Tight Junctions | 1 | 2006 | 20 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 133 | 0.060 |
Why?
|
| Granulocytes | 1 | 2006 | 70 | 0.060 |
Why?
|
| Tubulin | 1 | 2006 | 72 | 0.060 |
Why?
|
| Heterochromatin | 1 | 2006 | 84 | 0.060 |
Why?
|
| Drosophila | 2 | 2021 | 421 | 0.060 |
Why?
|
| Myeloid Cells | 1 | 2006 | 89 | 0.060 |
Why?
|
| Cell Death | 1 | 2006 | 271 | 0.060 |
Why?
|
| Fungal Proteins | 1 | 2005 | 144 | 0.060 |
Why?
|
| Repressor Proteins | 2 | 2007 | 330 | 0.060 |
Why?
|
| Cell Culture Techniques | 3 | 2010 | 178 | 0.060 |
Why?
|
| Fluorescence | 1 | 2004 | 83 | 0.060 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 1 | 2004 | 10 | 0.060 |
Why?
|
| Permeability | 1 | 2004 | 49 | 0.060 |
Why?
|
| Profilins | 1 | 2024 | 45 | 0.050 |
Why?
|
| Cell Cycle Proteins | 1 | 2005 | 384 | 0.050 |
Why?
|
| STAT1 Transcription Factor | 1 | 2022 | 35 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 128 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2003 | 112 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2002 | 108 | 0.050 |
Why?
|
| Protein Sorting Signals | 1 | 2002 | 55 | 0.050 |
Why?
|
| Oligopeptides | 1 | 2003 | 128 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2002 | 54 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2002 | 241 | 0.050 |
Why?
|
| Plasmids | 1 | 2002 | 279 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2002 | 193 | 0.050 |
Why?
|
| Models, Genetic | 1 | 2002 | 255 | 0.050 |
Why?
|
| Microglia | 1 | 2024 | 229 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 318 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2017 | 689 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2022 | 549 | 0.040 |
Why?
|
| Immunotherapy | 1 | 2022 | 228 | 0.040 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2002 | 167 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2017 | 1993 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 1557 | 0.040 |
Why?
|
| Time Factors | 3 | 2015 | 3615 | 0.040 |
Why?
|
| Structure-Activity Relationship | 2 | 2016 | 365 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2016 | 805 | 0.040 |
Why?
|
| Peptides | 1 | 2003 | 549 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2022 | 461 | 0.040 |
Why?
|
| Actins | 2 | 2015 | 259 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2011 | 113 | 0.040 |
Why?
|
| Cytokines | 1 | 2022 | 912 | 0.040 |
Why?
|
| Metaphase | 2 | 2010 | 34 | 0.040 |
Why?
|
| Genetic Heterogeneity | 1 | 2018 | 21 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 646 | 0.040 |
Why?
|
| PAX7 Transcription Factor | 1 | 2017 | 9 | 0.040 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2017 | 13 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2017 | 234 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2017 | 80 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2017 | 169 | 0.030 |
Why?
|
| Neoplasm Metastasis | 2 | 2009 | 186 | 0.030 |
Why?
|
| Neoplastic Stem Cells | 1 | 2018 | 196 | 0.030 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 170 | 0.030 |
Why?
|
| Cross-Linking Reagents | 1 | 2017 | 117 | 0.030 |
Why?
|
| Atlases as Topic | 1 | 2015 | 9 | 0.030 |
Why?
|
| Antibody Affinity | 1 | 2015 | 17 | 0.030 |
Why?
|
| Hybridomas | 1 | 2015 | 64 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2015 | 56 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 159 | 0.030 |
Why?
|
| Pressure | 1 | 2015 | 76 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 2015 | 100 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 88 | 0.030 |
Why?
|
| Micromanipulation | 1 | 2015 | 3 | 0.030 |
Why?
|
| Immunization | 1 | 2015 | 128 | 0.030 |
Why?
|
| Elasticity | 1 | 2015 | 40 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 2016 | 333 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 374 | 0.030 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2015 | 25 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 396 | 0.030 |
Why?
|
| Nuclear Envelope | 1 | 2015 | 48 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2016 | 424 | 0.030 |
Why?
|
| Acetylation | 1 | 2015 | 112 | 0.030 |
Why?
|
| C9orf72 Protein | 1 | 2015 | 104 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 650 | 0.030 |
Why?
|
| Osteosarcoma | 1 | 2015 | 53 | 0.030 |
Why?
|
| Nucleosomes | 1 | 2016 | 184 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 1597 | 0.030 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 347 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2015 | 127 | 0.030 |
Why?
|
| Machine Learning | 1 | 2015 | 153 | 0.030 |
Why?
|
| Models, Theoretical | 2 | 2006 | 256 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2015 | 868 | 0.030 |
Why?
|
| Bone Neoplasms | 1 | 2015 | 115 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 153 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2015 | 377 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2013 | 188 | 0.030 |
Why?
|
| Vaccination | 1 | 2015 | 335 | 0.030 |
Why?
|
| Primitive Streak | 1 | 2012 | 2 | 0.030 |
Why?
|
| DNA Damage | 1 | 2015 | 279 | 0.030 |
Why?
|
| Gastrula | 1 | 2012 | 12 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2012 | 48 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 717 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 190 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2015 | 486 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2013 | 144 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2012 | 214 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2016 | 1128 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2013 | 228 | 0.020 |
Why?
|
| CRISPR-Cas Systems | 1 | 2015 | 333 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 644 | 0.020 |
Why?
|
| Genotype | 1 | 2012 | 617 | 0.020 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2010 | 31 | 0.020 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2010 | 29 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2017 | 3228 | 0.020 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 679 | 0.020 |
Why?
|
| Intermediate Filaments | 1 | 2010 | 10 | 0.020 |
Why?
|
| Tyrosine | 1 | 2010 | 92 | 0.020 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2010 | 84 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2011 | 587 | 0.020 |
Why?
|
| Male | 3 | 2017 | 27760 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2009 | 110 | 0.020 |
Why?
|
| Computational Biology | 1 | 2010 | 333 | 0.020 |
Why?
|
| Cell Movement | 1 | 2009 | 428 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2009 | 274 | 0.020 |
Why?
|
| Pol1 Transcription Initiation Complex Proteins | 1 | 2007 | 8 | 0.020 |
Why?
|
| DNA, Ribosomal | 1 | 2007 | 29 | 0.020 |
Why?
|
| Chromatids | 1 | 2007 | 15 | 0.020 |
Why?
|
| Mathematics | 1 | 2006 | 32 | 0.020 |
Why?
|
| RNA, Ribosomal | 1 | 2007 | 53 | 0.020 |
Why?
|
| Interphase | 1 | 2007 | 68 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2007 | 76 | 0.020 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2006 | 17 | 0.020 |
Why?
|
| Diffusion | 1 | 2005 | 82 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2016 | 5280 | 0.020 |
Why?
|
| Paclitaxel | 1 | 2006 | 90 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2005 | 184 | 0.020 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2005 | 47 | 0.020 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2004 | 7 | 0.010 |
Why?
|
| Paxillin | 1 | 2004 | 9 | 0.010 |
Why?
|
| Focal Adhesions | 1 | 2004 | 23 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2004 | 31 | 0.010 |
Why?
|
| Cell Size | 1 | 2004 | 40 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2004 | 148 | 0.010 |
Why?
|
| Laminin | 1 | 2004 | 74 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 163 | 0.010 |
Why?
|
| Drug Combinations | 1 | 2004 | 147 | 0.010 |
Why?
|
| Heterozygote | 1 | 2004 | 161 | 0.010 |
Why?
|
| Collagen | 1 | 2004 | 115 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 1301 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2005 | 295 | 0.010 |
Why?
|
| Stem Cells | 1 | 2006 | 255 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2004 | 211 | 0.010 |
Why?
|
| Cytoskeletal Proteins | 1 | 2004 | 196 | 0.010 |
Why?
|
| RUNX1 Translocation Partner 1 Protein | 1 | 2002 | 11 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2002 | 22 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2002 | 27 | 0.010 |
Why?
|
| Subcellular Fractions | 1 | 2002 | 68 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 2002 | 52 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2002 | 63 | 0.010 |
Why?
|
| Zinc Fingers | 1 | 2002 | 96 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 427 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 450 | 0.010 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2002 | 256 | 0.010 |
Why?
|
| Biomarkers | 1 | 2006 | 1306 | 0.010 |
Why?
|
| Caenorhabditis elegans | 1 | 2005 | 623 | 0.010 |
Why?
|